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ABSTRACT 
Subtype C human immunodeficiency vírus type 1 (HIV-1) is rapidly diversifying among populations, which 
display extensiva polymorphism of genes encoding class I human leukocyte antigen (HLA) proteins, as detected in 
different regions of the world. Broadly conserved HIV-1 cytotoxic T cell (CTL) epitopes considering 128 subtype C 
externai glycoprotein gp120 sequences selected from GenBank were identified to A*0201, A*0301, A*1101 and 8*07 
HLA alleles using Epijen software. NetChop allowed to predict proteasome cleavage followed by prediction of binding 
to transport associated with antigen processing on TapPred. Glycosylation and positively selected sites within 
epitope sequences were also observed. Furthermore, three-dimensional structures of subtype C gp120 were predicted 
from consensus sequences in PHYRE and the PYMOL software was used to verify positions occupied by conserved 
epitopes. Finally, we predicted discontinuous B cell epitopes in DiscoTope 1.2. There is a recognized evolutionary 
force of HIV-1 to escape from B cells and CTL responses mutating sites that can negatively select the viral population. ' 
These types of analyses could be useful to understand HIV-1 epidemiology associated with polymorphisms in HLA 
alleles frequent in a determined region. 1t is expected that such knowledge may provide additional support for vaccine 
development. 
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1. lntroduction: 
Human immunodeficiency virus type 1 (HIV-1) is the etiological agent of Acquired 
lmmunodeficiency Syndrome (AIDS). Established HIV-1 infection causes selective depletion of CD4+ T 
cells, leading the host to a persistent immunodeficiency (Costin, 2007). HIV-1 genome is characterized by 
a high propensity to mutate, generating an extensiva genetic variation (Rambaut et ai., 2004). Such rapid 
evolution is the result of a combination of factors, including the lack of a proof-reading mechanism coupled 
with the high mismatch errar rates (Korber et ai., 2001) in viral RNA polymerase reverse transcriptase 
enzyme function. Moreover, events of genetic recombination during the viral cycle in co-infected host cells 
can generate new variants (Kandathil et ai., 2005). 
Subtype C is the most prevalent HIV-1 form outside Africa and it is responsible for more than 
48% of infections worldwide and the main cause of infections in lndia, plus several countries in Africa 
(Novitsky et ai., 1999; Soares et ai., 2005). Despite the high prevalence of subtype B in South America 
(Russell et ai. , 2000), in Southem Brazil, subtype C also circulates as a predominant form in infections 
due to recent introduction of this viral genotype in the region (Bello et ai., 2008). Recent data points to 
regional clusters within subtypes, showing significantly differences in subtype C among isolates from 
different parts of the world (WHO-UNAIDS, 2001). DiffJCulties on development of HIV vaccines are mainly 
due to this heterogeneity in viral populations. 
Cellular immune response, mediated by T lymphocytes, is responsible for controlling both 
chronic and acute HIV infections (McMichael and Rowland-Jones, 2001). Cytotoxic T lymphocytes (CTLs) 
recognize epitopes presented on surface of infected cells by human leukocyte antigen (HLA) class I 
molecules, inducing T -cell activation and clonal expansion of activated cells (Bemardin et ai., 2005). To 
achieve effective formation of the epitope-HLA complex, the peptide must to be cleaved in the proteasome 
in citoplasm of antigen presenting cells (APCs), followed by transport of the products by the transporter 
associated with antigen processing (TAP) protein before binding to HLA class I molecules (De Groot et ai., 
2001 ). A central role in controlling the virus is dependent on allelic variation in genes coding for HLA on 
the host's genome (Stephens, 2005). These polymorphisms are variable both within and between different 
ethnic groups and affect the binding and presentation of peptides in the context of HLA class I molecules 
(Carrington and O'Brien, 2003; McMichael and Rowland-Jones, 2001; Stephens, 2005). 
Viral mutations in specific sites provide an important mechanism to escape from CTL responses 
(Moore et ai., 2002). When variation occurs in genome regions selected by host cellular mechanisms to 
generate epitopes, CTL response may be inhibited, especially when such mutations alter amino acids 
used as anchors for HLA binding (MacKinney et ai., 2004). Sequence modifications could result in altered 
intracellular proteasome processing of peptides and consequent altered binding to HLA or interfere with 
binding of the HLA-peptide complex to the T cell receptor (De Groot et ai., 2003). Consequently, CTL 
escape mutants would lead rapidly to immune collapse and rapid progression to AIDS (Kmieciak et ai., 
1998). However, conserved residues in functional ar structural regions of a given protein must to be 
perpetuated to ensure viral replication, thus amino acid substitutions on these motifs are negatively 
selected (MacKinney et ai., 2004). 
Glycoprotein (gp) 120 is the surface unit protein of HIV envelope (env) spikes and is anchored 
by gp41, a transmembrane protein, to the viral envelope (Wyatt and Sodroski, 1998). Externai 
glycoproteins are important targets for the development of vaccines against AIDS, including specific CTL 
effectors elicitation approaches (Johnson et ai., 1991; Koenig et ai., 1988; Takahashi et ai., 1988). Recent 
evidences in HIV-infected individuais of circulating CTL against envelope proteins was obtained in 
experimental procedures (Takahashi et ai., 1988), revealing a potential target to viral epitope researches. 
Epitope mapping on virus proteins can provide useful information to vaccine development. 
Epitope-driven development of vaccines is especially important when dealing with pathogens that display 
high leveis of genetic diversity (Mata-Miranda et ai., 2007; Martin et ai., 2003). The use of experimental 
methods to discover relevant CTL epitopes - such as cloning and microarray analysis of overlapping 
peptides, may have low cost-effectiveness and the final results may be hampered by the presence of 
diversity among isolates for the epitopes found. To avoid these problems, a previous step putative epitope 
screening using bioinformatics tools, followed by confirmation in vitro, reduces the cost of development for 
candidate vaccines as well as may increases the efficacy of the experimental immunogens (Martin et ai., 
2003). Another possible advantage of this in sílica approach is the possibility to inquire whether the 
diverse HLA alleles present in a given population are prone to direct a immune response to different 
pathogen genotypes. The present study aims to predict the presence of CTL HIV-1 subtype C-specific 
epitopes on the gp-120 envelope protein, when analyzed for putative to HLA alleles prevalent in world's 
population. 
2. Material and Methods: 
2.1. Sequences targetting: 
Ali sequences analyzed in this study were selected from GenBank data base, between July and 
October 2008. We selected and analyzed only nucleotide sequences from gp120 region of HIV-1 subtype 
C, consisting of 320 samples. Fragments smaller than 1300 base pairs in length were rejected from the 
present study. 
Using Bioedit (Hall, 1999), the resultant sequences were renamed following a numeric arder of 
selection from GenBank. After screening and identification, fragments were submitted to Rega HIV 
Subtyping Tool version 2.0 (Oliveira et ai., 2005) and to Stanford database (Rhee et ai., 2003) to confirm 
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subtype and to verify the presence of premature stop codons respectively. Sequences not subtyped as C 
or/and presenting premature stop codons were also discarded. 
Alignment of these fragments was conducted using ClustaiX 2.0 software {Thompson et ai., 
1997). Based on reference sequences collected from Los Alamos Sequence Data Base, ClustaiX allowed 
us to identify clusters of sequences presenting specific pattems of HIV-1 subtype C from different parts of 
the world. Ali sequences were edited and verified manually using Bioedit. 
2.2. Construction of phylogenetic trees: 
Neighbor-joining phylogenetic trees were constructed under HKY distance matrix implemented 
in PAUP 4.0 software {Swofford, 2001) to analyze the relationship among sequences. Constructed trees 
allowed us to identify and discard fragments presenting high values of homology. 
2. 3. T ce/1 epitopes prediction: 
T cells epitope mapping were performed using Epijen online software {Doytchinova et ai., 
2006). lt provides information on epitope sequences according to selected HLA allele and scores the 
potential ability to bind to HLA class I molecules, considering its concentration in cell. 
Four HLA alleles were selected in Epijen to generate predicted epitopes: HLA A*0201, HLA 
A*0301, HLA A*1101 and HLA 8*07. Peptides recognized by these four alleles give rise to a predicted 
epitope recognition in more than 90% of the global population, regardless ethnicity {Sette and Sidney, 
1999). Threshold 0.0 to proteasome cleavage were used to 8*07 allele, wich prefer Phe or Trp at the C-
terminus {Doytchinova et ai. , 2006). The epitopes generated for 0201 , 0301 and 1101 HLA alleles were 
predicted using a threshold of 0.1. TAP prediction threshold of 5 were selected to 0201 , 0301 and 1101 
alleles, while to 8*07 allele a threshold of 3 were used as recommended by Doytchinova et ai. {2006). 1he 
5% threshold of available peptides sourced by one protein ranked by Epijen were use as a default value to 
ali HLA class I alleles. NetChop online software allowed us to reiterate the proteasome cleavage and 
select epitopes correctly processed. 
After prediction, we screened for conserved epitopes among ali sequences considering the 
same HLA allele. Similarity and variation observations of the most conserved epitopes, assisted by Bioedit 
software, were conducted to perform an evolutionary analyze and to verify conservation of anchor sites 
within epitopes. 
2.4. TAP binding: 
Binding to TAP protein was predicted by TapPred online program {Bhasin et ai. , 2007). We 
selected to predict T AP binders using cascade support vector machine model. Results were separated in 
three groups by TapPred {low, intermediate and high} according to predicted TAP binding value. 
2.5. Prediction of Glycosylation sites: 
Glycosylation is required for proper folding and conformational stability of the envelope 
glycoprotein and when component of an epitope can prejudice the binding to HLA class I molecule and 
may inhibit the adhesion of ligants to a given protein fragment (Fenouillet et ai. , 1994}. To verify potential 
sites with high specificity of N-glycosylation we used NetNGiyc 1.0 server software {Kukuruzinska and 
Lennon, 1998). NetOGiyc 3.1 server {Julenius et ai. , 2005} was accessed to predict 0-glycosylation 
within epitopes sequences. We only considered as likely glycosylation sites those with scores greater 
than 0.5. 
2.6. Selective pressure test: 
To test the hypothesis that amino acids substitutions within the most conserved epitopes could 
be undergoing different selective pressures (Yang, 1997) we tested differential models at individual sites. 
The analyses were performed using the nucleotide sequence of the proteasome cleavage fragments of the 
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most common epitopes found in this study. To verify conservation of proteasome cleavage sites we 
considered 3 codons before and after the cleavage sites. Likelihood methods were implemented in the 
PAML package (Yang et ai., 2000), version 3.14a, with several site-specific models: MO (one ratio)- which 
assumes constant selective pressure across codon sites and over time - and M3 (discrete) - which 
assumes discrete distribution to model heterogeneous ratio among sites, M1a (neutral), M2a (selection), 
M7: beta and M8: beta&w- with variable selective pressure across codon sites, were used to estimate 
selective pressure and test for positive selection. The selective pressure at the protein levei was measured 
by w, the ratio of non-synonymous to synonymous rates dN/dS, with w < 1, = 1, or > 1 indicating 
conserved, neutra! or adaptive evolution, respectively. The posterior probability of each codon site 
belonging to the positively selected category was computed by the naive empirical Bayes method (NEB) 
and Bayes empirycal Bayes (BEB). Finally, likelihood ratio test (LTR) analysis was used to determine: (1) if 
site heterogeneity selection was present and (2) if there were to be positive selection sites. 
2.7. Three-dimensional structure (3D) prediction: 
To construct a 30 model of HIV-1 gp120, a nucleotide consensus sequence of each subtype C 
group was defined using JaiView software (Ciamp et ai., 2004). PHYRE online program (Bennett-Lovsey 
et ai., 2008a, 2008b) was used to predict the 30 protein conformation based on the consensus sequence 
of each group. Four best models provided by PHYRE were selected to be checked by PROCHECK 
(Laskowski et ai., 1993; Morris et ai., 1992). This software allowed the selection of the best model based 
on the stereochemical quality of protein structure coordinates. The models generated were additionally 
analysed using Whatcheck to reevaluate stereochemistry and Verify 30 to check statistical potentials of 
mean force (Bowie et ai., 1991; Lüthy et ai., 1992; Vriend, 1990). The model which best satisfied the 
program's criteria was selected. 
PYMOL software (Delano, 2002) was used to verify position occupied by the most conserved 
epitopes in the 30 predicted protein structure o f each group o f H IV -1 subtype C gp 120. 
2. 8. B cell epitopes prediction: 
Prediction of discontinuous B cell epitopes from protein 30 structures of HIV-1 subtype C gp120 
was performed using Disco Tope 1.2 Server online program (Andersen et ai., 2006). This software utilizes 
calculations of surface accessibility and a novel epitope propensity amino acid score. The selected 
Disco Tope threshold score for epitope identification corresponded to a specificity of 75%. 
After prediction, regions found as B cell epitopes were marked in the previous constructed 
gp120 30 model proteins to each subtype C in PYMOL software. 
2.9. Similarity to human sequences: 
We used Ensembl Genome Server (Xose et ai., 2007) to verify similarity of the most conserved 
epitopes amino acid sequence to human genome sequence. This tool allowed us to identify possible 
epitopes that could induce autoimmunity due to similar characteristics of the human proteins to HIV-1 
gp120 protein after intra cellular processing. 
3. Results: 
3.1. Epitope selection: 
Following ou r cri teria to screen the peptides, 128 different sequences representing gp 120 
envelope protein of HIV-1 subtype C were selected from Genbank to predict T cell epitopes. According to 
the constructed filogenetic trees, 72 sequences showed high similarity to Brazilian reference sequence, 44 
were identified as Ethiopian subtype C and 12 as lndians. 
We found 140 different epitopes; however, considering the repetitions, 545 epitopes were 
mapped in HIV-1 subtype C sequences as a total amount. Ali epitopes found in this study were composed 
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of nine amino acids and, at least one epitope was identified by one HLA allele in each sequence (Figure 
1 ). 
To HLA A*0201 allele we found significant number of conserved and related epitopes in 
analysed sequences, showing 51 different epitopes (Figure 2) in 317 total antigenic peptides sequences. 
Despite the recognized conservation of some epitopes restricted to 0201 allele, 70% of the predicted 
epitopes were unique, not being recognized in more than one sequence. Our results showed that 0201 
was the only allele to recognize epitopes in ali sequences. Three epitopes (QMHEDIISL, CTHGIKPVV and 
NL TNNVKTI) had a high frequency and showed varying degrees of conservation. The previously 
described QMHEDIISL epitope (Kmieciak et ai. , 1998) was the most conserved epitope in our sequences 
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Figure 1. Three aligned amino acid sequences representing Brazilian, Ethiopian and lndian HIV-1 subtype C gp120 (not 
complet). Hachured peptides represents predicted epitopes to an HLA allele by Epijen online software. Green squares 
represents predicted epitopes resctrict to HLA A*0201 allele, orange squares represents peptides recognized to HLA A*0301 
allele restrictly, blue squares shown predicted epitopes to HLA A*1101 allele and yellow squares represent epitopes restricted 
to HLA 8*07 allele. Bicoloured squares show epitopes recognized by more than one HLA allele. 
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Considering ali variants, QMHEDIISL epitope family was found in 98% of the sequences. The 
NLTNNVKTI family was found in 61% of the sequences, presenting a main similarity value of 80%. We 
observed a significant prevalence of this peptide in HIV-1 sequences classified as 8razilian and lndian 
subtype C. Finally, the CTHGIKPW epitope was identified in 42% of the total sequences analysed in this 
work. 
We found only one Ethiopian subtype C sequence showing an epitope (ATNETIPEA) capable to 
be recognized for both HLA A *0201 and A *11 01 class I molecules (Figure 1 ). Five other sequences 
presented an epitope capable to bind in HLA class I molecules presented by HLA A*0201 and HLA 8*07 
alleles. 
8ased on in silico predictions, HLA A*0301 class I molecules recognized 37 possible antigenic 
peptides grouped in 15 different epitopes (Figure 1). The most conserved peptides appeared only in nine 
sequences and other six are fruit of amino acids substitutions. The RQAHCNISK predicted epitope 
exclusively bound to 0301 allele in two sequences recognized as brazilian subtype C and in one sequence 
identified as an lndian sequence. However, it could be recognized as an epitope for both HLA A*0301 e 
HLA A*1101 alleles in one sequence. 
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Figure 2. Absolute number of different epitopes predicted from HIV-1 gp120 amino acid sequences from three pattems of 
subtype C: Brazilian (72 sequences), Ethiopian (44 sequences) and lndian (12 sequences). Four HLA alleles were considered 
to the epitope prediction at Epijen software: HLA A*0201 , HLA A*0301, HLA A*1101 and HLA B*07. This graphic do not 
consider equal epitopes identified in different sequences, here we show only the quantities of varied epitopes. 
Fourteen different epitopes were recognized by HLA A*1101 allele. From the 36 total predicted 
antigenic peptides to this allele, 20 were CTRPNNNTR (Table 1). The CTRPNNNTR epitope also was 
recognized as a promiscuous epitope binding in 1101 and 0301 HLA molecules in 19 sequences. Other 
17 epitopes were recognized for both molecules, mainly in 8razilian sequences. Our results demonstrate 
that CTRPNNNTR epitope can bind to both alleles, however appeared to be an epitope to HLA A*0301 
only when it was an epitope to HLA A *11 01 , do not being recognized only by HLA A *0301. 
To HLA 8*07 from 39 different epitopes found in HIV-1 subtype C gp120 sequences only 3 
appeared in more than one sequence. This allele showed a high prevalence of non conserved epitopes 
(93%). 8inding affinity results from the peptides selected by Epijen did not show a conserved epitope 
ü f RGS- RlfH ' OTECA 
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Table 1. Most conserved HIV-1 subtype C gp120 epitopes found among Brazilian, Ethiopian and lndian 
subtype C sequences and related amino acid sequences presented restrictly by HLA A*0201 dass I 
molecules. 
Absolutea TAP Glycosylation 
Epitope Sequence Ofob 
Number Binding N o 
66 1,00 lntermidate No sites No sites 
15 0.89 lntermidate No sites 01 site 
25 0,89 lntermidate No sites No sites 
9 0,89 High No sites 01 site 
1 0,89 lntermidate No sites No sites 
1 0,89 lntermidate No sites No sites 
1 0,89 High No sites 01 site 
1 0,89 lntermidate No sites No sites 
1 0,89 lntermidate No sites No sites 
1 0,89 lntermidate No sites No sites 
1 0,89 lntermidate No sites 01 site 
2 0,78 High No sites 01 site 
1 0,78 High No sites No sites 
1 0,78 High No sites No sites 
126 0,80 
a Number of sequences that showed the epitope; 
b Percentage of similarity; 
(.)Similar amino acid presented by epitope sequence that showed high absolute number 
between Brazilian, Ethiopian and lndian subtypes to 07 allele. An Ethiopian subtype sequence showed 
one epitope (SVRIGPGQA) capable to be recognized for both HLA A*1101 and HLA 8*07 alleles. 
Six sequences were scored as conserved epitopes in gp120 subtype C gene to three HLA 
alleles (Table 2). 
3.2. TAP Binding: 
The majority of the epitopes showed an intermediate binding affinity to TAP (61.4%). Only 14 
sequences had a low predicted value. Our results show an intermediate binding affinity to conserved 
aminoacids sequences found here. 
3.3. Glycosylation sites prediction: 
Predicted N-glycosylation demonstrated that 45.7% of the epitopes found in this study were 
glycosylated. HLA A*1101 was the only one to have more than 60% of putatively glycosylated Epitopes. 
Sites of probable 0-glycosilation were found in 80% of epitopes. To ali epitopes predicted for 
1101 we found, at least one site of 0-glycosylation. Our data show that 93% of epitopes that are found to 
have 0-glycosylation sites are also N-glycosylated. 
QMHEDIISL epitope, most common in our sequences, showed no N-glycosylation nor 0-
glycosylation. Three of the most conserved epitope in this study had two sites of 0-glycosylation and one 
site of N-glycosylation. 
3.4 Selective Pressure Test 
ML methods were used to assess amino acid variation and differential pressure at individual 
sites. Analysing the fragment cleaved by proteasome, the peptide containing the CTHGIKPVV epitope 
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showed to be under negative selective pressure. The MO (one-ratio) model, which allows no variations in 
the substitutions taxes for the selected sequence, best fit to this fragment peptide. 
The QMHEOIISL and AITQACPKV (Figure 4A, 40, respectively) containing fragments fit to M3 
model (discrete). This model allows different taxes of variaton between sites. Finally, the fragments of 
NL TNNVKTI and CTRPNNNTR (Figure 48, 4C) epitopes showed sites identified as targets of positive 
selection (M2a model). For more information, see Table 1S in supplementary data. 
3.5. Three-dimensional structure prediction: 
Three models of the 30 structure of gp120 protein were obtained from PHYRE representing 
8razilian, Ethiopian and lndian C subtype (Figure 3). The models were constructed based on structures 
with high similarity to the 2b4c structure obtained from X-ray experiments (Kwong et ai., 1998). Only 
models possessing less than 2% of residues in disallowed regions of the Ramachandran plot were used 
(Table 3). 
Five conserved epitopes were identified in predicted proteins (Figure 3). The epitopes 
QMHEOIISL and CTHGIKPVV were arranged in an alpha helix and in a loop, respectively, in ali three 
models. Epitopes NL TNNVKTI and AITQACPKV were chiefly arranged in conserved sites on a loop. 
The CTRPNNNTR epitope was found in different positions among the three models. In 8razilian 
subtype C, the epitope was positioned in an alpha helix-loop-alpha helix motif, while in lndian subtype C 
structure it covered the end of an alpha helix and an entire loop, reaching the initial portion of an alpha 
helix. In the Ethiopian structure the CTRPNNNTR epitope was arranged starting at the end of an alpha 
helix, ending in a loop structure (Figure 3). 
Table 2. Most conserved epitopes present by HLA A*0201 , HLA A*0301 and HLA A*1101. 
Percentage of Sequences 
Brazilian Ethiopian lndian Total TAP HLA Epitope Sequence Subtype C Subtype C Subtype C Numberof binding 
(72 (44 (12 sequences 
sequences) sequences) sequences) 
a M H E o s L 50% 61% 25% 66 lntermediate 
A*0201 c T H G I K p v v 34.7% 50% 58.3% 54 lntermediate 
N L T N N v K T I 36.1% 9.1% 50% 36 lntermediate 
A I T a A c p K v 31.9% 9.1% 50% 33 lntermediate 
a M H E o v s L 5.5% 6.8% 66.6% 15 lntermediate 
A*0301 c T R p N N N T R* 12.5% 13.6% 33.3% 19 lntermediate 
A*1101 c T R p N N N T R* 29.2% 29.5% 41.6% 39 lntermediate 
* The CTRPNNNTR were recognized both by HLA A*0301 and HLA A*1101 
3.6. B ce/1 epitopes prediction: 
One hundred and thirty two 8-Cell epitope residues out of 330 total residues were predicted to 
8razilian subtype C gp120 consensus amino acid sequence. To Ethiopian sequence 130 out of 327 total 
residues were predicted as 8 cell epitopes and lndian subtype C consensus sequence revealed 122 
predicted residues as targets to 8 cells. 
Using PYMOL software predicted residues of each subtype C were mapped in the 30 structure 
of HIV-1 gp120 protein (Figures 30, 3E, 3F). Only 46 sites were predicted as in commom 8 cell epitopes in 
the three sequences. 
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3.7. Similarity to human sequences: 
Analyzing similarity in amino acids sequence from five most conserved epitopes found in this 
study to human genome we found two regions presenüng high homology to our epitopes. The 
QMHEDIISL epitope was found to have a identity of 87.5% to a region within a gene coding non-
characterized protein C6orf50 located in the short arm of chromossome 6. In the short arm of 
chromosome 9 we found another region of similarity (62.5%), within a gene coding C9orf105 
uncharacterized protein. 
The CTHGIKPVV epitope was found within gene MFI2 (CD228) coding a melanotransferrin 
precursor on long arm of chromosome 3 presenting an identity of 85.7%. 
Table 3. Plot statistics obtained from PROCHECK online software to gp120 HIV-1 subtype C protein 
models. Amino acid sequences were arranged in tertiary structural models by comparativa modeling 
using as template the PDB 2b4c structure. 
Sub!l~e C 
Evaluation 2b4c model Brazilian Ethiopian lndian 
(%} (%) (%} (%} 
Residues in most favoured regions 80.4 79.3 79.5 81.4 
Residues in additional allowed regions 18.6 18.6 18.1 16.6 
Residues in disallowed regions 0.7 1.4 1.7 1.0 
Number of non-glycine and non-proline 
0.3 0.7 0.7 1.0 
residues 
4. Discussion: 
The growing number of recombinant circulating forms of HIV-1 is a complicating factor for the 
development of an effective vaccine. The high rates of evolution in HIV-1 allow a rapid adaptation to the 
selective pressure exerted by host's immune response, both in humoral and cellular domains, becoming 
the main mechanism responsible for the viral escape from CTL response (Chackerian et ai., 1997). In the 
present study, we have identified a set of multiple HLA A and HLA B binding CD4 T-cell epitopes derived 
from computer analysis performed at Epijen tool and other complementary predictions. 
The diversity of responses to HIV considering different HLA alleles is evident in this study. HLA 
A*0201 allele was showed to display the potential to bind to several different putative epitope sequences, 
mainly in Ethiopian subtype C HIV-1, which presented 38 epitopes (Figure 2). The lndian HIV-1 subtype C 
showed a small number of different epitopes in Epijen sftware. However, this data can be attributable to 
the small number of sequences that do not represent the real diversity of this subtype. In fact there are 
only a few lndian sequences of HIV-1representing these genomic regions available in GenBank so far, but 
at least ali of information here showed about epitope prediction and protein analysis are new and could 
give support to further studies. 
Ou r results show a high number of epitopes recognized by 0201 allele when comparing the four 
alleles here analyzed. Previous reports (De Groot et ai., 2003 ; Shankar et ai., 1996) noticed a few 
number of HLA A2 epitopes and suggested that the HIV-1 genome has evolved to escape presentation by 
the highly prevalent HLA allele in world populations. However, these researches used neither non-specific 
subtype nor specific-viral gene-based approaches, reflecting in results ali the diversity of several genes of 
HIV-1. This methodology of epitope searching could, in this way, underestimate the rates of epitope 
binding to HLA class I molecules when compared to a specific subtype. Moreover, the results found here 
to 0201 allele show 70% of non-conserved epitopes, reflecting an effort of HIV-1 to escape from CTL 
response restricted to the most commonly found and evolutionary conserved HLA allele (De Groot et ai., 
9 
2003). Our findings are associated specifically with gp120 subtype C; nevertheless, the methodology 
presented here is based only on in sílica predictions and may not reproduce faithfully the whole biological 
Figure 3. Three-dimensional structure of HIV-1 gp120 based on nucleotide consensus sequence from Brazilian (A, D), Ethiopian (B, 
E) and lndian (C,F) subtype C showing the positions occupied by conserved epitopes. The diagrams A, 8 and C shows QMHEDIISL 
epitope position in orange, the epitope CTHGIKPVV in blue, the NLTNNVKTI epitope in magenta, the AITQACPKV epitope in red and 
the CTRPNNTR epitope in green located in the V3 loop. Epitopes QMHEDIINL and QMHEDVISL occupy the same position (shown in 
orange) due to the high similarity in nucleotide sequence. Models O, E an F represent predicted sites of discontinuous B cell epitopes 
from Disco Tope Server based on consensus sequence of Brazilian, Ethiopian and lndian subtype C, respectively. 
activity of the host immune system. Thus, experimental methods should be conducted to confirm the 
results obtained here. 
Macdonald et ai. (2000) found a positive correlation of A2 supertype, which includes 0201 
allele, to protection against infection and hypothesized that this supertype may mediate protection 
through the presentation of conserved epitopes that are shared by alleles within supertype. The 
conserved QMHEDIISL epitope family was recognized in 98% of sequences by HLA molecules of 0201 
alleles (Table 1). This high levei of conservation is in agreement with Kmieciak et ai. (1998) and may be 
attributable to the structural importance of this site to the protein function; any mutation in this sequence 
can affect the viral fitness and cause a negative selection by the host's immune system. The selective 
10 
pressure analysis in the proteasome cleavage fragment of this epitope showed that there is a negative 
pressure (w values varying between 0.10227 a 0.55911) acting in the peptide. Observed mutations in 
these similar sequences are selected to maintain the amino acid group in the positions P2 and P9 of 
binding to MHC class I molecules (Table 1). 
In a previous study of CTL response to HIV envelope glycoprotein (Kmieciak et ai. , 1998) the 
peptide KL TLPLCVTL was characterized by a remarkable degree of conservation and was capable of 
stimulating env-specific CTL responses in a large proportion of the HIV-infected individuais. Here, this 
epitope was identified once in a Brazilian subtype C sequence presenting a deletion in the fourth amino 
acid. This result emphasize the importance of subtype-specific analysis of epitopes to future vaccine 
development. 
HLA A*0301 and HLA A*1101 belong to the A3-like superfamily, which is defined by a shared 
preference for epitopes carrying A, L, I, V, M, S ar T at position 2 and R ar K at the C-terminus (Sidney et 
ai., 1996). Dueto this shared peptide motifs, HLA class I molecules from a same superfamily can present 
identical viral epitopes (promiscuous epitopes) as showed by 19 epitopes, mainly in Brazilian subtype C 
sequences. Previous studies showed that promiscuous epitope recognition among HLA class I allele 
belonging to HLA A3 superfamily is a common event (Threkeld et ai., 1997). However, recently, 
Lichterfeld et ai. (2006) found that promiscuous recognition of H IV-1 epitopes presented by HLA A *03 o r 
HLA A*11 occurs very rarely during natural infection (Lichterfeld et ai. , 2006). These contradictory data 
may be due to differential degrees of immunogenicity of each peptide to HLA class I molecule. 
Severa! studies have demonstrated that the principal neutralizing domain of HIV-1 lies within 
the third variable (V3) region arranged in a loop of gp120 (Hwang et ai. , 1991 ; Page et ai., 1992). Most of 
the amino acids of the V3 loop are highly variable between different subtypes of HIV-1; a Gly-Pro-Giy-Arg 
sequence at the tip of the loop is highly conserved among isolates derived from Europe and North 
America (Page et ai. , 1992) and is speculated as the major determinant of cell tropism in HIV-1 (Subema 
et ai., 1994). We provide relevant information of subtype differentiation, showing that Brazilian, Ethiopian 
and lndian subtype C, on the contrary of European and North American subtypes, do not present the 
conserved sequence GPGR. The predicted CTRPNNNTR peptide, arranged within V3 loop, is both 
promiscuous, recognized by 0301 and 1101 HLA alleles, and restrict only to 1101 allele, as showed in 
previous study (De Groot et ai., 2003). This epitope seems to be arranged in a positive selective pressure 
site, however in the exact sequence of the epitope (CTRPNNNTR) we found a relaxed selective 
pressure (w =1). This discordance may be attributed to the worldwide distribution of HLA A*0301 allele. 
Thus, HIV-1 could be adapted to the CTL response associated with 0301 HLA due to its wide circulation 
and selection (De Groot et ai., 2003; MacDonald et ai. , 2000; Moore et ai., 2002). Our results showed a 
low capacity of HLA A *0301 to recognize epitopes in H IV-1 subtype C sequences. 
The HLA 87 supertype has been shown to be associated with high viral loads and rapid 
progression to disease (Kiepiela et ai. , 2004). De Groot et ai. (2008) in an experimental method found 
that the HLA 87 restricted epitopes were conserved in as many as 93% of comparison sequences 
considering severa! subtypes and viral genes. Our results show a low tax of epitope conservation to this 
supertype and may be explained by the specificity predictions to HIV-1 subtype C gp120 protein. 
The transport antigen protein (TAP) is an important component of the intracellular immune 
response. Human TAP genes carry limited polymorphism, however, when these variants are analyzed, 
no diferences in the spectrum of transported epitopes was shown (Daniel et ai. , 1997). Previous 
association report some interaction between specific HLA class I alleles and specific T AP variants 
(Henderson et ai., 1992). Some peptides are able to access the endoplasmatic reticulum (ER) via other 
TAP independent pathways. Thus, TAP binding affinity values prediction to HLA A *0201 and HLA A *11 01 
molecules do not totally define the cellular capacity for transport peptides from citosol to ER before 
binding to HLA molecule (Henderson et ai., 1992; Smith and Lutz, 1996). 
HIV genome encodes no gene products capable of synthesizing carbohydrates, it utilizes the 
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Figure 4. Posterior probabilities that each codon of the epitopes from the site classes under severa! models, calculated using the na'lve empirical Bayes (NEB), lhe Bayes 
empirycal Bayes (BEB) procedure produced virtually identical posterior probabilities; (A) QMHEDIISL epitope - M3 model (discrete); (B) NLTNNVKTI epitope - M2a 
(selection) model; (C) CTRPNNNTR epitope- M2a (selection) model. (D) AITQACPKV epitope - M3 model (discrete); The CTHGIKPW epitope (MO - one-ratio model) did 
not show any variation . 
directly encoded by viral genome. The folding of viral glycoproteins, the transmission of the virus and the 
nature of the immune response to infection are ali profoundly affected by this glycosylation (Scanlan et 
ai ., 2007). Chackerian et ai . (1997) using simian virus as a model showed that the escape from antibody 
recognition appeared to be influenced by either 0-linked or N-linked carbohydrate additions. 0-linked 
glycosylation is the addition of N-acetyl-galactosamine to serine or threonine residues and act facilitating 
the vira! particles penetration into mucosa! secretions (Calvete and Sanz, 2008). We found some 
conservation in the position of N-linked glycans due to the close filogenetic relationship among Brazilian, 
Ethiopian and lndian subtype C. Glycosylation, as a product of the host cellular mechanism, can protect 
epitopes within the vira! protein due to the fact that B cells can not access the 30 structure of gp120 
(McCaffrey et ai. , 2004). Associating O and N-glycosylation to B cell epitopes for the most conserved T 
cell epitopes we observed that severa! peptides which were predicted as targets for B cells are also 
glycosylated, excepting the QMHEOIISL epitope that was identified as a B cell target, but was not 
predicted as glycosylated. Further studies should investigate 
Three gp120 30-models were obtained from PHYRE based on consensus deduced amino acid 
sequences of Brazilian, Ethiopian and lndian subtype C. Models were arranged based on high similarity 
to the solved gp120 structure (POB 10 2b4c; Kwong et ai., 1998). Our models showed sub-optimal 
validation values, however, it is a reflection from comparative modeling with 2b4c structure, which shows 
less than 90% in most allowed regions (Table 3). Application of this method is an effort to increases 
efficiency to obtain useful information about potential structural B-cell epitopes within gp120 protein. The 
present study found a correlation in position of the most abundant CTL and B-cell discontinuous 
epitopes. Conserved epitopes to HLA A *0201 , HLA A*0301 and HLA A *11 01 class I molecules seems to 
be arranged mainly in N-terminal position within gp120 protein as observed by Kmieciak et ai. (1998), 
which is structurally similar to host chemokines and may interacts with C04 (Sharon et ai. , 2003). This 
result suggests that predicted conserved epitopes may retain a structural and functional importance to 
the protein, thus are maintained along the virus evolution. 
Two peptides presenting high similarity to human proteins were found; however analysis of 
proteasome cleavage of human sequence did not reveal maintenance of these peptides to correctly bind 
to TAP and to be presented to HLA class I molecule (data not showed). 
We explored HLA class I molecules relationships in a variety of ways, including class 1-TAP 
combinations, class l-regional subtype, class 1-glycosylation sites and class 1-30 protein structure. 
Oespite the recognized regional-specific epidemiology of HIV-1 it is important to emphasize the constant 
circulation of vira! forms between different regions allowing the dispersion of variable subtypes around the 
world. Thus, our study allows the understanding of the influence of some HLA genotypes to HIV-1 
infection and could give support to the development of future vaccine programs. 
5. Conclusions: 
This study provides an important role of the bioinformatics approach to selecting CTL and B-
cell discontinuous epitopes based in different human HLA genotype, which may be highly influential in 
the immune response to HIV-1. We conclude that vira! mutations are extensively pressured by host's 
immune response. There is a recognized effort of HIV-1 to escape from B cells and CTL responses 
mutating sites that can negatively select the vira! population. Glycosylation sites added by host cellular 
mechanisms are a striking example of vira! adaptation to penetrate and not be recognized by immune 
response. However, some sites of the genome have to be conserved due to the important function of the 
encoded protein. So, CTL epitopes are HLA-restricted and individual hosts play an important mechanism 
of selection to escape mutations in the diversity of HLA polymorphisms in human population. Additionally, 
it will be important to continue analyzing epitope variability in other vira! proteins and subtypes of HIV-1. 
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10. Supplementary Data 
T bl 15 P d l"k l"h d res under models of variable w ratios amon sites • 
Ne~ted model dN/dS" Parameter estimates . e L TR 
pa1rs ' c-. 2 e 
MO: one-ratio(1) 0.3029 w=0.30287 -652.319849 
M3: discrete (51 p0=0.50091,p1 =0.21112,(p2 =0.28797) w0=0.10227, w1 =0.55911, 0.0216941 0.3303 w2 = 0.55911 -646.581287 
M1a: neutra! (1) 0.4527 pO = 0.68873, (p1 = 0.31127) (wO = 0.20535), (w1 =1) -649.458657 0.13374 
M2a:seleclion( 3) 0.4524 p0=0.68901, p1 =0.21947, (p2=0.09151) (wO = 0.20522), (w1 =1), w2 = 1 -647.446801 
M7: beta (2) 
0.3327 p= 0.94853 q= 1.88844 -645.518354 
M8: beta&w (4) pO= 0.97097, p= 1.00919, q= 2.14954 '(p1= 0.02903) w = 1 0.999 0.0950 -647.877106 
MO: one-ratio(1) 0.2910 w= 0.29100 -1168.363631 
M3: discrete (5) p0=0.73881 ,p1 =0.06860,(p2=0.19258) w0=0.14995, w1 =0.31213, > 0.00001 0.6329 w2= 2.59991 -1090.288617 
M1a: neutra! (1) 0.3082 pO = 0.78013, (p1 = 0.21987) , (wO = 0.11321), (w1 =1) -1102.773805 
112uelection(31 pO= 0.78031, p1 = 0.10448, (p2= 0.11521) (wO = 0.14544), (w1 =1), >0.00001 0.5926 w2 = 3.25199 -1088.967201 
M7: beta (2) 
0.3705 p= 0.44989 q= 0.76352 -1115.724392 
M8: beta&w (4) pO= 0.80706 p= 18.97489 q= 96.34941 (p1= 0.19294) w = 2.68016 > 0.00001 0.6497 -1091.611148 
AIO: one-ratio(11 0.04201 w = 0.04201 -314.917919 
M3: discrete (5) pO =0.27863, p1 =0.38460, (p2 =0. 0.33678) wO= 0.04204, 0.754562 0.0420 w1 =0.04204, w2 = 0.04204 -313.969063 
M1a: neutra! (1) 0.0419 pO = 1, (p1 =O) (wO =0.04188), (w1 =1) -313.873131 
M2a:seleclion(3) p0=1, p1 =0, (p2=0) (wO = 0.04213), (w1 =1), w2 = 7.48064 0.400441 0.0421 -312.957942 
M7: beta (2) 0.0433 p= 4.51742 q= 99.00000 -313.894358 
MB: beta&w (4) pO= 1 p= 4.50930 q= 99 (p1= O) w = 1.85724 0.999 0.0950 -315.370443 
MO: one-ratio(1) 0.4271 w = 0.42705 -1165.717128 
> 0.00001 
M3: discrete (5) 
0.5983 pO = 0.19845, p1 = 0.37337, (p2 = 0.42818) w O =O, w1 = 0.15783, w2 = 1 -1088.6397 49 




pO= 0.57044, p1 = 0.28033, (p2= 0.14923) (wO = 0.11475), (w1 =1), w2= 2.37620 
-1089.282788 
M7: beta (2) 0.3684 p= 0.17259 q= 0.29584 -1091.597101 
MB: beta&w (4) 0.6354 pO= 0.84961 p= 0.29483q= 0.51309 (p1= 0.15039) w=2.16370 -1085.220722 0.001701 27 
MO: one-ratio(1) 0.3549 w=0.35489 -ô82.062480 
M3: discrete (51 pO = 0.63140, p1 = 0.29405, (p2 = 0.07455) w O= 0.03267, w1 = 0.73994, > 0.00001 0.3810 w2= 1.91561 -640.436294 
M1a: neutra! (1) 0.3810 pO = 0.64132, (p1 =O. 0.3586), (wO = 0.03482), ( w1 =1) -643.944089 0.260249 
M2a:selection(3) 
0.4629 pO= 0.63934, p1 = 0.29502 (p2= 0.06564) (wO = 0.03831), (w1 =1), w2 = 2.18443 -642.597972 
M7: beta (2) 0.3328 p= 0.18308 q= 0.36713 -644.448591 0.282471 
M8: beta&w (4) 0.3997 ~= 0.92703 ~= 0.20966 q= 0.54463 (~1= 0.07297) ! w = 1.94651 -643.181441 
a The number after lhe model oode, in parenlheses, is lhe number of free parameters in lhe w distribution. b This dN/dS ratio is an average over ali sites in lhe 
epitopes alignment c Parameters in parenlheses are not free parameters; w dN/dS ratio; p, proportion of sites in w; MO-M3: x2 df=4; M1 a-M2a: x2 df=2; M7-
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